Triple negative breast cancer (TNBC) is an aggressive form of breast cancer (BC) with a
poor prognosis. Second, patients cannot benefit from targeted therapy, except for those with …

Context: Triple negative breast cancer (TNBC) is a heterogeneous group of diseases that is
negative for esterogen receptor (ER) progesteron receptor (PR) and human epidermal …

Background Triple-negative breast cancer (TNBC) has a poor prognosis compared to other
breast cancer subtypes. This systematic review and meta-analysis examines whether known …

The triple receptor-negative breast cancer (TNBC) subtype is characterized by the lack of
expression of both hormone receptors as well as lack of over-expression and/or lack of gene …

Triple-negative breast cancer (TNBC) is a subtype of aggressive breast cancer and
characterized by a lack of the expression of estrogen receptor, progesterone receptor and …

Breast cancer is the most prevalent cancer among women worldwide. Among the different
breast cancer subtypes, triple-negative breast cancer (TNBC), which is more prevalent …

The term triple-negative breast cancer (TNBC) defines breast tumors that do not express
estrogen receptors, progesterone receptor or epidermal growth factor receptor HER2 on …

Breast cancer (BC) is the most frequent tumor worldwide. Triple-negative BCs are
characterized by the negative estrogen and progesterone receptors and negative HER2 …

Triple negative breast cancer (TNBC) is a heterogeneous disease comprehending different
orphan breast cancers simply defined by the absence of ER/PR/HER-2. Approximately 15 …

Triple-negative breast cancers (TNBC), characterized by absence of the estrogen receptor
(ER) and progesterone receptor (PR) and lack of overexpression of human epidermal …